These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25306767)

  • 21. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 22. Report of the 2015 APhA House of Delegates.
    J Am Pharm Assoc (2003); 2015; 55(4):364-75. PubMed ID: 26161480
    [No Abstract]   [Full Text] [Related]  

  • 23. Could State Regulations be the Next Frontier in Preemption Jurisprudence? Drug Compounding as a Case Study.
    Brown NA; Tomar E
    Food Drug Law J; 2016; 71(2):271-99. PubMed ID: 29140058
    [No Abstract]   [Full Text] [Related]  

  • 24. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
    Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
    [No Abstract]   [Full Text] [Related]  

  • 25. Traditional vs. nontraditional pharmacy.
    Allen LV
    Int J Pharm Compd; 2013; 17(4):351. PubMed ID: 24261152
    [No Abstract]   [Full Text] [Related]  

  • 26. Compounding problems and compounding confusion: federal regulation of compounded drug products and the FDAMA circuit split.
    Boodoo JM
    Am J Law Med; 2010; 36(1):220-47. PubMed ID: 20481406
    [No Abstract]   [Full Text] [Related]  

  • 27. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
    Hinkley KN
    State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
    [No Abstract]   [Full Text] [Related]  

  • 28. 2013 State Compounding Legislation Tracker.
    Miller DG
    Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacists' liability: what my pharmacy law professor did not cover.
    Rizo M; Seamon M
    Int J Pharm Compd; 2013; 17(4):290-3. PubMed ID: 24261143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Battles over compounding from bulk drugs move forward.
    Clark A
    J Am Vet Med Assoc; 2005 Jul; 227(1):9-10. PubMed ID: 16013529
    [No Abstract]   [Full Text] [Related]  

  • 31. Preventing medication errors with nimodipine by compounding proper dosage forms.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(5):364-8. PubMed ID: 24459780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASHP guideline: minimum standard for pharmaceutical services in ambulatory care. American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 1999 Sep; 56(17):1744-53. PubMed ID: 10512507
    [No Abstract]   [Full Text] [Related]  

  • 33. The "Lists": What Do They Mean?
    Voliva J
    Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
    [No Abstract]   [Full Text] [Related]  

  • 34. Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):351. PubMed ID: 28333682
    [No Abstract]   [Full Text] [Related]  

  • 35. APhA voices pharmacists' concerns.
    Martin S
    Am Pharm; 1993 May; NS33(5):25-7. PubMed ID: 8333404
    [No Abstract]   [Full Text] [Related]  

  • 36. Contemporary pharmaceutical compounding.
    Allen LV
    Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA, states discuss pharmacy compounding regulatory framework.
    Traynor K
    Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
    [No Abstract]   [Full Text] [Related]  

  • 38. Federal court strikes down compounding regulations.
    Harteker LR
    Am J Health Syst Pharm; 2001 Apr; 58(8):638, 640, 643. PubMed ID: 11329752
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 40. ASHP Guidelines on Outsourcing Sterile Compounding Services.
    Am J Health Syst Pharm; 2015 Oct; 72(19):1664-75. PubMed ID: 26386108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.